Cargando…

Cardiac dysfunction and remodeling regulated by anti-angiogenic environment in patients with preeclampsia: the ANGIOCOR prospective cohort study protocol

BACKGROUND: Cardiovascular diseases (CVD) are cause of increased morbidity and mortality in spite of advances for diagnosis and treatment. Changes during pregnancy affect importantly the maternal CV system. Pregnant women that develop preeclampsia (PE) have higher risk (up to 4 times) of clinical CV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ullmo, Johana, Cruz-Lemini, Monica, Sánchez-García, Olga, Bos-Real, Lidia, Fernandez De La Llama, Patricia, Calero, Francesca, Domínguez-Gallardo, Carla, Garrido-Gimenez, Carmen, Trilla, Cristina, Carreras-Costa, Francesc, Sionis, Alessandro, Mora, Josefina, García-Osuna, Álvaro, Ordoñez-Llanos, Jordi, Llurba, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653611/ https://www.ncbi.nlm.nih.gov/pubmed/34879854 http://dx.doi.org/10.1186/s12884-021-04263-w

Ejemplares similares

Impact of Angiogenic and Cardiovascular Biomarkers for Prediction of Placental Dysfunction in the First Trimester of Pregnancy
por: Nan, Madalina Nicoleta, et al.
Publicado: (2023)

Longitudinal Behavior of Left-Ventricular Strain in Fetal Growth Restriction
por: Domínguez-Gallardo, Carla, et al.
Publicado: (2023)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers
por: Garrido-Giménez, Carmen, et al.
Publicado: (2023)

Reduction in Preterm Preeclampsia after Contingent First-Trimester Screening and Aspirin Prophylaxis in a Routine Care Setting
por: Trilla, Cristina, et al.
Publicado: (2022)

First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors: Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study
por: Trilla, Cristina, et al.
Publicado: (2022)

Maternal History and Uterine Artery Doppler in the Assessment of Risk for Development of Early- and Late-Onset Preeclampsia and Intrauterine Growth Restriction
por: Llurba, Elisa, et al.
Publicado: (2009)

Risk Assessment after ST-Segment Elevation Myocardial Infarction: Can Biomarkers Improve the Performance of Clinical Variables?
por: Garcia-Osuna, Alvaro, et al.
Publicado: (2022)

Pro-angiogenic therapeutics for preeclampsia
por: Eddy, Adrian C., et al.
Publicado: (2018)

Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy
por: Palomo, Marta, et al.
Publicado: (2022)

The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia
por: Nikuei, Pooneh, et al.
Publicado: (2015)

Disrupted Balance of Angiogenic and Antiangiogenic Signalings in Preeclampsia
por: Furuya, Mitsuko, et al.
Publicado: (2011)

Angiogenic Properties of Menstrual Stem Cells Are Impaired in Women with a History of Preeclampsia
por: Varas-Godoy, Manuel, et al.
Publicado: (2019)

The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia
por: Abascal-Saiz, Alejandra, et al.
Publicado: (2022)

The effect of placental angiogenic and anti-angiogenic factors on pregnancy outcome in patients with early onset preeclampsia
por: Kara, Mustafa, et al.
Publicado: (2021)

Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders
por: Rana, Sarosh, et al.
Publicado: (2022)

A different type of acute myocarditis: a case report of acute autoimmune myocarditis mediated by anti-PD-1 T lymphocyte receptor (pembrolizumab)
por: Salido Iniesta, Mario, et al.
Publicado: (2020)

Pregnancy-Induced Hypertension and Preeclampsia: Levels of Angiogenic Factors in Malaysian Women
por: Yelumalai, Suseela, et al.
Publicado: (2010)

Interferon-alpha and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia
por: Andrade, Danieli, et al.
Publicado: (2014)

Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis
por: Veisani, Yousef, et al.
Publicado: (2019)

Angiogenic Properties of Placenta-Derived Extracellular Vesicles in Normal Pregnancy and in Preeclampsia
por: Gebara, Natalia, et al.
Publicado: (2021)

The Potential for Placental Activation of PPARγ to Improve the Angiogenic Profile in Preeclampsia
por: Grimaldi, Brooke, et al.
Publicado: (2022)

The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia
por: Ramma, Wenda, et al.
Publicado: (2012)

Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia
por: March, Melissa I., et al.
Publicado: (2015)

Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes
por: Leaños-Miranda, Alfredo, et al.
Publicado: (2017)

Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia
por: Weel, Ingrid C., et al.
Publicado: (2016)

Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome
por: Stepan, Holger, et al.
Publicado: (2020)

A Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth Restriction
por: Kwiatkowski, Sebastian, et al.
Publicado: (2016)

Serum Levels of Angiogenic Factors Distinguish Between Women with Preeclampsia and Normotensive Pregnant Women But Not Severity of Preeclampsia in an Obstetric Center in Turkey
por: Atakul, Tolga
Publicado: (2019)

Angiogenic Factors in Women Ten Years after Severe Very Early Onset Preeclampsia
por: Gaugler-Senden, Ingrid P. M., et al.
Publicado: (2012)

Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia
por: Dobierzewska, Aneta, et al.
Publicado: (2016)

Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy
por: Saura, Cristina, et al.
Publicado: (2021)

Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
por: Hamza, Reham Z., et al.
Publicado: (2021)

Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia
por: Suvakov, Sonja, et al.
Publicado: (2019)

The potential association between a new angiogenic marker fractalkine and a placental vascularization in preeclampsia
por: Szewczyk, Grzegorz, et al.
Publicado: (2021)

Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia
por: Nunes, Priscila Rezeck, et al.
Publicado: (2021)

La pensée scientifique moderne
por: Ullmo, Jean
Publicado: (1969)

The Capacity of APOB-Depleted Plasma in Inducing ATP-Binding Cassette A1/G1-Mediated Macrophage Cholesterol Efflux—But Not Gut Microbial-Derived Metabolites—Is Independently Associated with Mortality in Patients with ST-Segment Elevation Myocardial Infarction
por: Canyelles, Marina, et al.
Publicado: (2021)

The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
por: Cohen, Allison L., et al.
Publicado: (2014)

Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia
por: Palomaki, Glenn E, et al.
Publicado: (2015)

The Role of Angiogenic and Antiangiogenic Factors in the Second Trimester in the Prediction of Preeclampsia in Pregnant Women With Type 1 Diabetes
por: Holmes, Valerie A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d39vcbn9ctq982bbvh8mddletb